JP2002262828A - Composition for suppressing increase of lipid peroxide level containing mannooligosaccharide - Google Patents

Composition for suppressing increase of lipid peroxide level containing mannooligosaccharide

Info

Publication number
JP2002262828A
JP2002262828A JP2001070410A JP2001070410A JP2002262828A JP 2002262828 A JP2002262828 A JP 2002262828A JP 2001070410 A JP2001070410 A JP 2001070410A JP 2001070410 A JP2001070410 A JP 2001070410A JP 2002262828 A JP2002262828 A JP 2002262828A
Authority
JP
Japan
Prior art keywords
mannose
composition
coffee
oligosaccharide
lipid peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001070410A
Other languages
Japanese (ja)
Other versions
JP4684440B2 (en
Inventor
Yasuyuki Nakamura
保幸 中村
Hiromitsu Hoshino
宏充 星野
Shigeyoshi Fujii
繁佳 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto AGF Inc
Original Assignee
Ajinomoto General Foods Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto General Foods Inc filed Critical Ajinomoto General Foods Inc
Priority to JP2001070410A priority Critical patent/JP4684440B2/en
Publication of JP2002262828A publication Critical patent/JP2002262828A/en
Application granted granted Critical
Publication of JP4684440B2 publication Critical patent/JP4684440B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Abstract

PROBLEM TO BE SOLVED: To provide a composition for suppressing the increase of lipid peroxide level by using unused resources. SOLUTION: The composition effective for suppressing the increase of lipid peroxide level contains an oligosaccharide as a main component. The oligosaccharide is composed mainly of 1-10 molecules of bonded monosaccharides composed mainly of mannose and produced by hydrolyzing mannan obtained from coffee beans and/or extraction residue of coffee.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、マンノースを主体とし
たオリゴ糖類を主成分とする過酸化脂質の上昇抑制作用
を有する組成物、およびその組成物を用いた飲食物およ
び飼料に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition mainly composed of oligosaccharides mainly composed of mannose and having an action of inhibiting the elevation of lipid peroxide, and to a food, drink and feed using the composition. .

【0002】生命活動の維持には酸素が欠かせないが、
生体内の活性酸素は強い毒性を持っている。近年の研究
により酸素障害が成人病や老化等に深く関わっているこ
とが分かってきている。特に生体膜の構成成分である不
飽和脂肪酸は酸素ラジカルによる酸化を受けやすく脂質
過酸化連鎖反応を介して過酸化脂質を生成する。この過
酸化脂質が動脈硬化、肝臓病のみならず発癌、老化等に
関与しているものと推定されている。このような疾患の
予防のために、個々の食物中の抗酸化物質の検索、作用
機序の解明についての研究が進められているが、まだ充
分に解明されるに至っていない。また、抗酸化物質の食
物への添加が考えられるが、食物の持つ本来の風味が変
わることや経済的な欠点も残る。
[0002] Oxygen is indispensable for maintaining life activities,
Active oxygen in the living body has strong toxicity. Recent studies have shown that oxygen impairment is deeply involved in adult diseases and aging. In particular, unsaturated fatty acids, which are constituents of biological membranes, are susceptible to oxidation by oxygen radicals and generate lipid peroxides through a lipid peroxidation chain reaction. It is presumed that this lipid peroxide is involved not only in arteriosclerosis and liver disease but also in carcinogenesis and aging. In order to prevent such diseases, research on searching for antioxidants in individual foods and elucidation of the mechanism of action has been advanced, but has not been sufficiently elucidated yet. In addition, the addition of antioxidants to foods is conceivable, but the original flavor of foods changes and economical disadvantages remain.

【0003】近年、D−マンノースがβ−1,4結合し
た化合物であるβ−1,4マンノビオースなどのβ−
1,4−マンノオリゴ糖の持つ生理機能が注目されてお
り、家畜の有害菌汚染防止物質としても知られている
(特開平8−38064)。また人間の糖タンパク質の
糖鎖の重要な部分構造にはD−マンノースがβ−1,4
結合したマンノオリゴ糖が含まれており、飲食品原料と
してのみならず、医薬品の原料としての応用も期待され
ている(特昭58−21278、特開平8−998
9)。
In recent years, β-mannose biose such as β-1,4 mannobiose, which is a compound in which D-mannose is β-1,4 bonded, has been developed.
The physiological functions of 1,4-mannooligosaccharides have attracted attention, and are also known as substances for preventing harmful bacterial contamination of livestock (Japanese Patent Application Laid-Open No. 8-38064). D-mannose is β-1,4 as an important partial structure of the sugar chain of human glycoprotein.
It contains bound manno-oligosaccharides and is expected to be used not only as a raw material for food and drink but also as a raw material for pharmaceuticals (Japanese Patent Publication No. 58-21278, Japanese Patent Application Laid-Open No. 8-998).
9).

【0004】また、本発明は未利用資源の有効活用にも
関するものである。コーヒーの抽出残渣は従来、そのほ
とんどが焼却あるいは産業廃棄物として処理されてき
た。近年になり、コーヒー抽出残渣が堆肥原料あるいは
活性炭原料として利用されるようになってきたが、それ
らは未利用資源の高度利用という観点からは十分とはい
えず、更なるコーヒー抽出残渣の高度利用の方法を確立
することは重要課題となっている。
[0004] The present invention also relates to the effective use of unused resources. Conventionally, most coffee extraction residues have been incinerated or treated as industrial waste. In recent years, coffee extraction residues have been used as a raw material for compost or activated carbon.However, they are not sufficient from the viewpoint of advanced utilization of unused resources. It is an important issue to establish the method of the above.

【0005】[0005]

【従来の技術および発明が解決しようとする課題】従
来、マンノース残基を有する単糖、およびオリゴ糖類の
生理機能については有害細菌の感染を予防するために飼
料へ添加する方法(特開平08−38064)、植物の
生長を促進させるために植物または土壌に施用する方法
(特開昭63−215606)等が提案されているが、
ヒトが摂取するにあたり、どのような生理機能を示すか
は、ほとんど不明であり、コンニャクの加水分解物であ
るグルコマンナンオリゴ糖を摂取することによるビフイ
ドバクテリウム増殖方法(特開昭58−212780)
が提案されているのみである。しかもその内容は、ビフ
イドバクテリウム菌を増殖させる方法であり、その他の
腸内有害菌も増殖させてしまう虞れがある。また、コン
ニャクの加水分解物には糖鎖中にマンノース残基以外に
グルコース残基が多く含まれており、マンノース残基以
外の糖残基がほとんど含まれていないマンノオリゴ糖に
ついての報告はまだない。
2. Description of the Related Art Conventionally, the physiological functions of monosaccharides and oligosaccharides having a mannose residue are added to feed in order to prevent infection by harmful bacteria (Japanese Patent Application Laid-Open No. 08-2008). 38064), a method of applying to plants or soil to promote plant growth (JP-A-63-215606) and the like have been proposed.
It is almost unknown what physiological function is exhibited by humans, and a method for growing bifidobacteria by ingesting glucomannan oligosaccharide, which is a hydrolyzate of konjac (Japanese Patent Application Laid-Open No. 58-21780) )
Is only proposed. Moreover, the method is a method of growing bifidobacteria, and there is a possibility that other intestinal harmful bacteria may also grow. In addition, the konjac hydrolyzate contains a large amount of glucose residues other than mannose residues in the sugar chain, and there is no report on a manno-oligosaccharide containing almost no sugar residues other than mannose residues. .

【0006】マンノース残基を有する単糖類およびオリ
ゴ糖類の製造方法としては、例えば、コンニャク、ユリ
等に含まれるグルコマンナンや、グアガム、ローカスト
ビーンガム等に含まれるガラクトマンナン等を酸や酵素
で加水分解する方法(特開昭63−49093)、コプ
ラミールから酵素加水分解によりマンノビオースを製造
する方法(特開平11−18793)等が提案されてい
る。
As a method for producing monosaccharides and oligosaccharides having a mannose residue, for example, glucomannan contained in konjac, lily and the like, and galactomannan contained in guar gum, locust bean gum and the like are hydrolyzed with an acid or an enzyme. A method of decomposing (JP-A-63-49093) and a method of producing mannobiose from copra meal by enzymatic hydrolysis (JP-A-11-18793) have been proposed.

【0007】しかし、グルコマンナンやガラクトマンナ
ンの加水分解物からグルコース、ガラクトース等が混在
しマンノースを主要構成糖とするマンノオリゴ糖と呼ぶ
にはかけ離れた物であった。
However, glucomannan or galactomannan hydrolyzate is mixed with glucose, galactose, etc., and is far from a manno-oligosaccharide having mannose as a main constituent sugar.

【0008】また、コーヒー抽出残渣を加水分解するこ
とにより、糖鎖中にマンノース残基以外の糖残基の含有
量が少ないマンノオリゴ糖類を得ることはできる(米国
特許第4,484,012号、米国特許第4,508,
745号、米国特許第4,798,730)が、着色物
質、脂質、蛋白質、塩、酸等が混在しているため、食
品、医薬品等への適用が制限される。
[0008] Manno-oligosaccharides having a low content of sugar residues other than mannose residues in the sugar chain can be obtained by hydrolyzing the coffee extraction residue (US Pat. No. 4,484,012, U.S. Pat. No. 4,508,
No. 745, U.S. Pat. No. 4,798,730) contains a coloring substance, a lipid, a protein, a salt, an acid and the like.

【0009】さらに、コプラミールを加水分解およびマ
ンノースを縮合または転移反応させることにより、糖鎖
中にマンノース残基以外の糖残基の含有量が少ないマン
ノオリゴ糖類を得ることができる(特開平11−018
791)が、これらの生理機能および飲食料品への利用
については未知である。本発明は、通常の食生活習慣の
大幅な変更を伴うことなく、しかも過酸化脂質の上昇抑
制効果が優れ経済的で簡便な飲食物を提供することを目
的としている。
Furthermore, by hydrolyzing copra meal and subjecting mannose to condensation or transfer reaction, mannooligosaccharides having a low content of sugar residues other than mannose residues in the sugar chain can be obtained (JP-A-11-018).
791), however, their physiological functions and their use in food and drink are unknown. An object of the present invention is to provide an economical and simple food and drink that does not involve a drastic change in normal eating habits, has an excellent effect of suppressing a rise in lipid peroxide, and is excellent.

【0010】[0010]

【課題を解決するための手段】本発明者らは、これらの
ような課題を解決するために鋭意検討の結果、マンナン
を多く含む食品素材、主に、コーヒー抽出粕加水分解物
から、糖鎖中にマンノース残基以外の糖残基の含有量が
少ない重合度1〜10のマンノオリゴ糖類又はマンノー
スとグルコースおよびガラクトースのような単糖類の少
なくとも1種とが1〜10分子結合したマンノースを主
体としたオリゴ糖類に過酸化脂質の上昇を抑制する効果
を有することを見いだし、本発明を完成するに至った。
さらに、無着色、無酸の糖鎖中にマンノース残基以外の
糖残基の含有量が少ない重合度1〜10のマンノオリゴ
糖類を得ることで、食品への適用範囲を飛躍的に広げる
ことができることを見いだした。
Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve these problems, and as a result, have found that a food material containing a large amount of mannan, mainly a coffee extract lees hydrolyzate, Mannose oligosaccharides having a degree of polymerization of 1 to 10 having a low content of sugar residues other than mannose residues or mannose and at least one kind of monosaccharide such as glucose and galactose are mainly composed of mannose in which 1 to 10 molecules are bonded. The inventors have found that the oligosaccharides have an effect of suppressing an increase in lipid peroxide, and have completed the present invention.
Further, by obtaining mannooligosaccharides having a degree of polymerization of 1 to 10 having a low content of sugar residues other than mannose residues in an uncolored, acid-free sugar chain, the range of application to food can be dramatically expanded. I found what I could do.

【0011】本発明は、マンノースを主体とした単糖類
が1〜10分子結合したオリゴ糖類又はマンノースとグ
ルコースおよびガラクトースのような単糖類の少なくと
も1種とが1〜10分子結合したマンノースを主体とし
たオリゴ糖類を主成分とすることを特徴とする過酸化脂
質の上昇抑制作用を有する組成物に関する。当該組成物
は、マンノースもしくはマンノースを主体とした単糖が
2〜10分子結合した単一の化合物、または、それらの
中から選ばれた2種以上のオリゴ糖を主成分とする組成
物を意味する。本発明の組成物において、マンノースが
1〜10分子結合した単一の化合物ないしはそれらの中
から選ばれた2種以上の化合物を含有する過酸化脂質の
上昇抑制作用を有する組成物であることが望ましい。
The present invention relates to an oligosaccharide having 1 to 10 molecules of a monosaccharide mainly composed of mannose or a mannose mainly having 1 to 10 molecules of a monosaccharide such as glucose and galactose bound to mannose. The present invention relates to a composition having an effect of suppressing an increase in lipid peroxide, characterized in that the composition has an oligosaccharide as a main component. The composition means a single compound in which 2 to 10 molecules of mannose or a monosaccharide mainly containing mannose are bonded, or a composition mainly containing two or more oligosaccharides selected from them. I do. In the composition of the present invention, the composition may be a single compound in which 1 to 10 molecules of mannose are bonded or a composition having an action of suppressing an increase in lipid peroxide containing two or more compounds selected from them. desirable.

【0012】本発明の組成物において、総固形分に対
し、マンノースを主体とする単糖類が1〜10分子結合
したオリゴ糖類の合計含有割合が60重量%以上が好ま
しく、80重量%以上がさらに好ましい。
In the composition of the present invention, the total content of oligosaccharides having 1 to 10 monosaccharides mainly composed of mannose bonded to the total solid content is preferably at least 60% by weight, more preferably at least 80% by weight. preferable.

【0013】本発明における組成物の糖組成においては
マンノース残基の割合が70重量%以上、更に好ましく
は80重量%以上であるものが望ましい。マンノース残
基の割合が70%に満たないと、効果が大きく期待でき
ないとともに、甘味度も増し適用の幅が狭まる傾向にあ
る。構成糖としては、マンノース以外には、加水分解す
る出発物質にもよるがグルコース、ガラクトースなどが
含まれるが必要に応じて除去することもできる。組成物
中の遊離のマンノース含量については50%以下に抑え
られたものが望ましい。50重量%を越えると、マンノ
ース由来の苦味のために、適用の範囲に制約を受ける傾
向にある。さらに、マンノースを主体としたオリゴ糖類
は、マンノースが2〜6分子結合したオリゴ糖類である
ことが好ましい。そして、その結合様式は、βー1,4
結合であることが好ましい。
In the saccharide composition of the composition of the present invention, the ratio of mannose residues is preferably 70% by weight or more, more preferably 80% by weight or more. If the ratio of mannose residues is less than 70%, the effect cannot be expected to be large, and the sweetness is also increased, and the range of application tends to be narrowed. The constituent sugars include glucose, galactose, etc., depending on the starting material to be hydrolyzed, in addition to mannose, but can be removed as necessary. The content of free mannose in the composition is desirably suppressed to 50% or less. If it exceeds 50% by weight, the range of application tends to be restricted due to bitterness derived from mannose. Further, the oligosaccharide mainly composed of mannose is preferably an oligosaccharide having 2 to 6 molecules of mannose bonded thereto. And the binding mode is β-1,4
It is preferably a bond.

【0014】本発明においては、マンナンを加水分解処
理することによって得られたマンノースを主成分とする
過酸化脂質の上昇抑制作用を有する組成物が好ましい。
また、当該マンナンがコーヒー豆および/またはコーヒ
ー抽出残渣から得られるものであることが好ましい。
In the present invention, a composition having a mannose-based main component and a lipid peroxide peroxide-suppressing effect obtained by hydrolyzing mannan is preferred.
Further, it is preferable that the mannan is obtained from coffee beans and / or coffee extraction residue.

【0015】さらに、本発明においては、コーヒー抽出
残渣を加水分解処理することによって得られたマンノー
スを主成分とする過酸化脂質の上昇抑制作用を有する組
成物が好ましい。
Further, in the present invention, a composition having a mannose-based main component and a lipid peroxide-up suppressing effect obtained by hydrolyzing a coffee extraction residue is preferred.

【0016】また、本発明は、上記に説明した本発明に
係る組成物を含有する飲食物および飼料にも関する。な
お、本発明に係る組成物は、飲食物、飼料のみならず化
粧品、医薬品等幅広い分野で使用することが可能であ
る。本発明の組成物は、飲食物として人が口から摂取す
ることにより過酸化脂質の上昇を抑制する効果を発揮す
る。
The present invention also relates to foods and drinks and feeds containing the above-described composition according to the present invention. The composition according to the present invention can be used not only in foods and drinks and feeds but also in a wide range of fields such as cosmetics and pharmaceuticals. The composition of the present invention exerts an effect of suppressing an increase in lipid peroxide by being ingested by a person through the mouth as food or drink.

【0017】本発明の組成物は、例えばココナッツ椰子
から得られるコプラミール、フーク、南アフリカ産椰子
科植物HuacraPalm、ツクネイモマンナン、ヤ
マイモマンナンよりマンナンを抽出後、酸加水分解、高
温加熱加水分解、酵素加水分解の中から選ばれる1種ま
たは2種以上の方法で処理し、活性炭処理、吸着樹脂処
理、イオン交換樹脂処理、イオン交換膜処理等の方法で
精製された糖混合物および/またはコンニャクイモ、ユ
リ、スイセン、ヒガンバナ等に含まれるグルコマンナ
ン、ローカストビーンガム、グアーガム等に含まれるガ
ラクトマンナンを酸加水分解、高温加熱加水分解、酵素
加水分解の中から選ばれる1種または2種以上の方法で
処理し、活性炭処理、吸着樹脂処理、イオン交換樹脂処
理、イオン交換膜処理等の方法で分離精製し構成糖とし
てマンノースの比率を高めたものであってもよい。
The composition of the present invention is obtained by extracting mannan from, for example, copra meal, hook obtained from coconut coconut palm, HuacraPalm from South Africa, tsukuneimomannan, and yamimomannan, and then subjecting to acid hydrolysis, high temperature heat hydrolysis, enzyme hydrolysis. A sugar mixture and / or konjac potato, lily, which are treated by one or more methods selected from the group consisting of: activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, ion exchange membrane treatment, etc. Glucomannan contained in narcissus, amaryllidaceae, etc., galactomannan contained in locust bean gum, guar gum, etc. is treated by one or more methods selected from acid hydrolysis, high temperature heat hydrolysis, and enzyme hydrolysis. , Activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, ion exchange membrane treatment Or it may be an increased ratio of mannose as a way to separation and purification constituent sugars and the like.

【0018】さらに、コーヒー生豆または焙煎したコー
ヒー豆を酸加水分解、高温加熱加水分解、酵素加水分解
の中から選ばれる1種または2種以上の方法で処理し、
活性炭処理、吸着樹脂処理、イオン交換樹脂処理、イオ
ン交換膜処理等の方法で精製することによって得ること
ができる。
Further, the green coffee beans or the roasted coffee beans are treated by one or more methods selected from the group consisting of acid hydrolysis, high temperature heat hydrolysis and enzymatic hydrolysis,
It can be obtained by purification by a method such as activated carbon treatment, adsorption resin treatment, ion exchange resin treatment, or ion exchange membrane treatment.

【0019】あるいは、使用済みコーヒー残渣を、酸加
水分解、高温加熱加水分解、酵素加水分解の中から選ば
れる1種または2種以上の方法で可溶化処理した水溶液
を活性炭処理、吸着樹脂処理、イオン交換樹脂処理、イ
オン交換膜処理等の方法で精製することによって得るこ
とができる。
Alternatively, an aqueous solution obtained by solubilizing a used coffee residue by one or more methods selected from acid hydrolysis, high-temperature heat hydrolysis and enzymatic hydrolysis is treated with activated carbon, adsorbed resin, It can be obtained by purification by a method such as ion exchange resin treatment and ion exchange membrane treatment.

【0020】一般に、焙煎粉砕コーヒーを商業用の抽出
器にて抽出すると、その際に焙煎コーヒーに含まれるガ
ラクトマンナンの側鎖であるガラクトースが可溶化した
り、アラビノガラクタンが加水分解によって可溶化す
る。従って、コーヒー残渣中にはマンナンが豊富であ
り、しかも直鎖構造をとっているものと推定される。一
方、セルロースは分解されにくく残渣として残っている
が、セルロースを分解せずにマンナンを特異的に加水分
解する条件を適宜選択することにより、マンノースを主
体とするオリゴ糖を得ることができる。
Generally, when roasted and ground coffee is extracted with a commercial extractor, galactose which is a side chain of galactomannan contained in the roasted coffee is solubilized, and arabinogalactan is hydrolyzed. Solubilize. Therefore, it is presumed that coffee residue is rich in mannan and has a linear structure. On the other hand, although cellulose is hardly decomposed and remains as a residue, an oligosaccharide mainly composed of mannose can be obtained by appropriately selecting conditions for specifically hydrolyzing mannan without decomposing cellulose.

【0021】本発明において使用されるコーヒー抽出残
渣は通常の液体コーヒーあるいはインスタントコーヒー
製造工程において抽出されたものであれば、常圧下、加
圧下抽出であろうと、またいかなる起源、製法のコーヒ
ー抽出残渣であっても使用することができる。
[0021] The coffee extraction residue used in the present invention may be extracted under normal pressure or pressure, as long as it is extracted in a usual liquid coffee or instant coffee production process, and coffee extraction residue of any origin and production method. Can also be used.

【0022】コーヒー抽出残渣を酸および/または熱に
より加水分解しオリゴ糖類を高純度に含むように調製し
た組成物を液体コーヒー、インスタントコーヒー等にそ
のまま添加して使用することもできるが、必要に応じて
活性炭、イオン交換樹脂等で脱色、脱臭、脱酸等の精製
処理をしたものを添加した方がコーヒー本来の味、香り
のより豊かなコーヒーを提供することができる。
A composition prepared by hydrolyzing a coffee extraction residue with acid and / or heat and containing oligosaccharides with high purity can be used as it is by adding it directly to liquid coffee, instant coffee or the like. Accordingly, it is possible to provide a coffee having a richer original taste and aroma by adding a product which has been subjected to a purification treatment such as decolorization, deodorization, and deoxidation with activated carbon, an ion exchange resin or the like.

【0023】更に、カラムクロマトグラフィー等で特定
の重合度をもつマンノオリゴ糖に分画した上で使うこと
もできる。以下に本発明において、コーヒー抽出残渣か
らマンノースを主成分とする単糖類が1〜10分子結合
したオリゴ糖類を含有する組成物を製造する代表的な方
法を述べるが、必ずしも以下の製法に限定されるもので
はない。
Further, it can be used after fractionating into mannooligosaccharides having a specific polymerization degree by column chromatography or the like. Hereinafter, in the present invention, a typical method for producing a composition containing oligosaccharides in which monosaccharides containing mannose as a main component are bonded in 1 to 10 molecules from a coffee extraction residue is described, but is not necessarily limited to the following production method. Not something.

【0024】コーヒー抽出残渣を分解する方法として
は、酸および/または高温により加水分解する方法と酵
素により分解する方法が挙げられる。酸および/または
高温により加水分解する方法としては特開昭61−96
947号、特開平2−200147号等に開示されてい
る。商業用のコーヒー多段式抽出系において出てくる使
用済みコーヒー残渣を反応容器中において酸触媒を添加
して加水分解することもできるし、酸触媒を添加せずに
高温で短時間処理して加水分解することによっても得る
ことができる。管形栓流反応器を使用するのが便利であ
るが比較的高温で短時間の反応を行わせるのに向いてい
るものならば、いかなる反応器を使用しても良好な結果
が得られる。反応時間と反応温度を調節し、可溶化して
加水分解させることによってDP10〜40のマンナン
をDP1〜10のマンノオリゴ糖に分解し、その後コー
ヒー残渣と分離してマンノオリゴ糖類を得る。
Methods for decomposing the coffee extraction residue include a method of hydrolyzing with an acid and / or high temperature and a method of decomposing with an enzyme. A method of hydrolyzing with an acid and / or high temperature is described in JP-A-61-96.
947, JP-A-2-200147 and the like. Spent coffee residue from a commercial coffee multi-stage extraction system can be hydrolyzed by adding an acid catalyst in a reaction vessel, or by treating at a high temperature for a short time without adding an acid catalyst. It can also be obtained by decomposition. It is convenient to use a tubular plug flow reactor, but good results can be obtained using any reactor that is suitable for conducting a reaction at a relatively high temperature for a short time. The reaction time and reaction temperature are adjusted, solubilized and hydrolyzed to decompose the mannan of DP10 to 40 into mannooligosaccharides of DP1 to 10, and then separate from the coffee residue to obtain mannooligosaccharides.

【0025】「マンナン」という用語は、広くd−マン
ノースからなる多糖を意味する。単糖d−マンノースは
アルドヘキソースであり、d−グルコース中のカルボキ
シル基に隣接する炭素に結合している水酸基の立体配置
が逆になっているものである。
The term "mannan" refers to a polysaccharide consisting broadly of d-mannose. The monosaccharide d-mannose is an aldohexose, in which the configuration of the hydroxyl group bonded to the carbon adjacent to the carboxyl group in d-glucose is reversed.

【0026】「オリゴ糖」は、単糖の数が比較的少ない
ポリマーを意味する。とくに、本明細書においては、単
糖の数が10以下であるポリマーをさす。マンノース
は、便宜上DP1のオリゴ糖とするが、厳密にいうとオ
リゴ糖は2以上の単糖からなるものをさす。
"Oligosaccharide" means a polymer having relatively few monosaccharides. In particular, in the present specification, it refers to a polymer in which the number of monosaccharides is 10 or less. Mannose is a DP1 oligosaccharide for convenience, but strictly speaking, an oligosaccharide refers to one composed of two or more monosaccharides.

【0027】「重合度」または「DP」とは、オリゴ糖
を構成している単糖の数を意味する。従って、たとえば
マンノースが4つの単糖から構成されているマンノオリ
ゴ糖の重合度は4であるのでDP4と記載する。
"Degree of polymerization" or "DP" means the number of monosaccharides constituting an oligosaccharide. Therefore, for example, the degree of polymerization of a manno-oligosaccharide in which mannose is composed of four monosaccharides is 4, and is described as DP4.

【0028】「コーヒー残査」とは、たとえば大気条件
中で抽出した後のいわゆるコーヒー抽出粕を意味する。
また、酵素により分解する方法としては、例えばコーヒ
ー抽出残渣を水性媒体に懸濁させ、ここへ例えば市販の
セルラーゼおよびヘミセルラーゼ等を加えて撹拌しなが
ら懸濁させればよい。酵素の量、作用させる温度および
その他の条件としては、通常の酵素反応に用いられる
量、温度、条件であれば特に問題はなく、使用する酵素
の最適作用量、温度、条件およびその他の要因によって
適宜選択すればよい。
"Coffee residue" means, for example, so-called coffee extract cake after extraction under atmospheric conditions.
As a method of decomposing with an enzyme, for example, a coffee extraction residue may be suspended in an aqueous medium, and then, for example, a commercially available cellulase, hemicellulase, or the like may be added thereto and suspended with stirring. The amount of the enzyme, the temperature at which it is allowed to act, and other conditions are not particularly limited as long as it is the amount, temperature, and conditions used in a normal enzyme reaction, and may depend on the optimal amount of the enzyme to be used, temperature, conditions, and other factors. What is necessary is just to select suitably.

【0029】上記の方法によって得られたマンノースを
主体とする単糖類が1〜10分子結合したオリゴ糖類を
含有する組成物を含む反応液は、必要に応じて精製を行
う。精製法としては、骨炭、活性炭、炭酸飽充法、吸着
樹脂、マグネシア法等で脱色を行い、イオン交換樹脂、
イオン交換膜、電気透析等で脱塩、脱酸を行う。精製法
の組み合わせおよび精製条件としては、マンノースが1
〜10分子結合したマンノオリゴ糖類を含む反応液中の
色素、塩、および酸等の量およびその他の要因に応じて
適宜選択すればよい。
The reaction solution containing a composition containing oligosaccharides having 1 to 10 molecules of monosaccharides mainly composed of mannose obtained by the above method is purified as necessary. As a purification method, decolorization is performed by bone charcoal, activated carbon, carbonation saturation method, adsorption resin, magnesia method, etc.
Desalting and deoxidizing are performed by ion exchange membrane, electrodialysis and the like. The combination of the purification methods and the purification conditions are as follows.
What is necessary is just to select suitably according to the quantity of a pigment | dye, a salt, an acid, etc. in the reaction liquid containing the mannooligosaccharide which couple | bonded 10-10 molecules, and other factors.

【0030】次に、本発明を実施例および試験例により
具体的に説明する。 実施例1 コーヒー抽出残渣を反応器に送りやすくするために、ま
ず粉砕して粒径を約1mmにした。次いで、総固形分濃
度が約14w/w%の水と粉砕物からなるスラリーを調
製し4mの熱栓流反応器内において熱処理した。滞留時
間8分に対応する速度で高圧蒸気とともに栓流反応器に
ポンプ輸送し、6.35mmφオリフィスを用いて約2
10℃に維持した。その後、大気圧下に噴出することに
よって、反応を急止した。できたスラリーを濾過して、
不溶性固形分から可溶性固形分を含む液を分離した。こ
の可溶性固形分含有液を活性炭、吸着樹脂で脱色し、さ
らにイオン交換樹脂で脱塩した後、濃縮、乾燥してマン
ノースを主体とする単糖類が1〜10分子結合したオリ
ゴ糖類を含有する組成物を収率14%で得た。このよう
にして得られた過酸化脂質の上昇抑制作用を有する組成
物のDP分布は、例えばDP1;2.4%、DP2;2
6.6%、DP3;20.2%、DP4;17.8%、
DP5;10.9%、DP6;8.9%、DP7;6.
0%、DP8;3.6%、DP9;1.9%、DP1
0;1.7%で、糖鎖中のマンノース残基の含有量は9
0%であるが、DP分布および糖鎖中のマンノース残基
の含有量は加水分解条件により種々の値をとりうる。オ
リゴ糖のDP1としてはマンノース等、DP2としては
マンノビオース等、DP3としてはマンノトリオース
等、DP4としてはマンノテトラオース等、DP5とし
てはマンノペンタオース等、DP6としてはマンノヘキ
サオース等、DP7としてはマンノヘプタオース等、D
P8としてはマンノオクタオース等、DP9としてはマ
ンノノナオース等、DP10としてはマンノデカオース
等で、結合様式はβ−1,4結合である。生後4週齢の
ウィスター系雄性ラットを使用して、固形飼料で1週間
予備飼育した。その時の体重を基準に1群5匹の2群に
分けて試験食(対照群)、本発明に係る上記組成物を試
験食中に5%となるように添加した試験食(MOS群)
をそれぞれ4週間与えた。試験食の組成を表1に示し
た。
Next, the present invention will be described specifically with reference to examples and test examples. Example 1 In order to easily send a coffee extraction residue to a reactor, the residue was first ground to a particle size of about 1 mm. Next, a slurry consisting of water and a pulverized product having a total solid content of about 14 w / w% was prepared and heat-treated in a 4 m hot plug flow reactor. Pumped with high pressure steam to the plug flow reactor at a rate corresponding to a residence time of 8 minutes, using a 6.35 mmφ orifice for approximately 2 minutes.
Maintained at 10 ° C. The reaction was then halted by squirting under atmospheric pressure. Filter the resulting slurry,
A liquid containing a soluble solid was separated from an insoluble solid. The soluble solid content-containing liquid is decolorized with activated carbon and an adsorption resin, and further desalted with an ion exchange resin, and then concentrated and dried to contain an oligosaccharide in which 1 to 10 mannose-based monosaccharides are bonded. Was obtained in a yield of 14%. The DP distribution of the thus-obtained composition having a lipid peroxide increase inhibitory action is, for example, DP1; 2.4%, DP2;
6.6%, DP3; 20.2%, DP4; 17.8%,
DP5: 10.9%, DP6: 8.9%, DP7;
0%, DP8; 3.6%, DP9; 1.9%, DP1
0; 1.7%, and the content of mannose residues in the sugar chain was 9
Although it is 0%, the DP distribution and the content of mannose residues in the sugar chain can take various values depending on the hydrolysis conditions. Examples of oligosaccharides such as mannose and the like as DP1, mannobiose and the like as DP2, mannotriose and the like as DP3, mannotetraose and the like as DP4, mannopentaose and the like as DP5, and mannohexaose and the like as DP6. As DP7, mannoheptaose etc., D
P8 is mannooctaose or the like, DP9 is mannononaose or the like, DP10 is mannodecaose or the like, and the binding mode is β-1,4 bond. Four-week-old Wistar male rats were preliminarily reared on solid feed for one week. A test meal (control group) divided into two groups of 5 animals per group based on the body weight at that time, and a test meal (MOS group) in which the above composition according to the present invention was added so as to be 5% in the test meal.
For 4 weeks each. Table 1 shows the composition of the test meal.

【0031】飼料配合Feed formulation

【表1】 [Table 1]

【0032】飼育は、室温22±2℃、12時間の明暗
サイクルの飼育室で行い、飼料および飲料水は自由摂取
とした。試験終了時にエーテル麻酔下で開腹し、腹部下
大静脈から全血採血した。採血した血液を用いて過酸化
脂質を自動分析計にて測定した。結果は表2に示すよう
に、本発明に係る組成物の摂取により、MOS群では血
液中過酸化脂質濃度が有意に低減した。
The breeding was performed in a breeding room with a 12-hour light-dark cycle at room temperature of 22 ± 2 ° C., and feed and drinking water were freely taken. At the end of the test, the abdomen was opened under ether anesthesia, and whole blood was collected from the inferior vena cava. Lipid peroxide was measured by an automatic analyzer using the collected blood. As shown in Table 2, the intake of the composition according to the present invention significantly reduced the blood lipid peroxide concentration in the MOS group by taking the composition according to the present invention.

【0033】[0033]

【表2】 [Table 2]

【0034】実施例2 コーヒーミックスの製造法 インスタントコーヒー2.0gと実施例1で調整したマ
ンノオリゴ糖0.5gとを混合しコーヒーミックスを調
製した。このミックスをお湯140mlで溶かし、官能
評価した結果、従来のインスタントコーヒーの味を十分
維持し、しかも、より濃厚で味わい深いコーヒー飲料で
あった。日常の食習慣を変えることなく血液中の過酸化
脂質の上昇抑制効果が期待できる。
Example 2 Method for Producing a Coffee Mix A coffee mix was prepared by mixing 2.0 g of instant coffee and 0.5 g of mannooligosaccharide prepared in Example 1. This mixture was dissolved in 140 ml of hot water and subjected to a sensory evaluation. As a result, the taste of the conventional instant coffee was sufficiently maintained, and the coffee drink was richer and more flavorful. The effect of suppressing an increase in lipid peroxide in blood can be expected without changing daily eating habits.

フロントページの続き Fターム(参考) 2B150 AA10 DC13 DC15 4B018 MD31 MD57 ME06 MF01 MF07 MF10 4B027 FB22 FC06 FK10 FQ11 Continued on front page F term (reference) 2B150 AA10 DC13 DC15 4B018 MD31 MD57 ME06 MF01 MF07 MF10 4B027 FB22 FC06 FK10 FQ11

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】マンノースを主体とした単糖類が1〜10
分子結合したオリゴ糖類又はマンノースとグルコースお
よびガラクトースのような単糖類の少なくとも1種とが
1〜10分子結合したマンノースを主体としたオリゴ糖
類を主成分とすることを特徴とする過酸化脂質の上昇抑
制作用を有する組成物。
(1) a monosaccharide mainly containing mannose is 1 to 10:
Elevated lipid peroxide characterized in that it comprises, as a main component, a mannose-based oligosaccharide in which 1 to 10 molecule-bound oligosaccharides or mannose and at least one monosaccharide such as glucose and galactose are bound. A composition having an inhibitory action.
【請求項2】総固形分に対し、マンノースを主体とする
単糖類が1〜10分子結合したオリゴ糖類又はマンノー
スとグルコースおよびガラクトースのような単糖類の少
なくとも1種とが1〜10分子結合したマンノースを主
体としたオリゴ糖類の合計含有割合が60w/w%以上
である請求項1に記載の組成物。
2. An oligosaccharide in which 1 to 10 molecules of a monosaccharide mainly composed of mannose are bonded to the total solid content, or 1 to 10 molecules of a mannose and at least one type of monosaccharide such as glucose and galactose are bonded. The composition according to claim 1, wherein the total content of oligosaccharides mainly composed of mannose is 60 w / w% or more.
【請求項3】糖組成において、マンノース残基の割合が
70w/w%以上である請求項1乃至2のいずれかに記
載の組成物。
3. The composition according to claim 1, wherein the ratio of mannose residues is at least 70 w / w% in the saccharide composition.
【請求項4】マンノースを主体としたオリゴ糖類が、マ
ンノースが2〜6分子結合したオリゴ糖類の中から選ば
れた1種以上であることを特徴とする請求項1乃至2の
いずれかに記載の組成物。
4. The method according to claim 1, wherein the oligosaccharide mainly composed of mannose is at least one selected from oligosaccharides having 2 to 6 molecules of mannose bonded thereto. Composition.
【請求項5】請求項1乃至4のいずれかに記載の組成物
がマンナンを加水分解処理することによって得られる組
成物。
5. A composition obtained by subjecting the composition according to claim 1 to hydrolysis treatment of mannan.
【請求項6】前項のマンナンがコーヒー豆および/また
はコーヒー抽出残渣から得られるものである請求項1乃
至5のいずれかに記載の組成物。
6. The composition according to claim 1, wherein said mannan is obtained from coffee bean and / or coffee extract residue.
【請求項7】請求項1乃至6のいずれかに記載の組成物
を含有する飲食物または飼料。
7. A food, drink or feed containing the composition according to any one of claims 1 to 6.
JP2001070410A 2001-03-13 2001-03-13 Lipid peroxide elevation-suppressing composition containing mannooligosaccharide Expired - Fee Related JP4684440B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001070410A JP4684440B2 (en) 2001-03-13 2001-03-13 Lipid peroxide elevation-suppressing composition containing mannooligosaccharide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001070410A JP4684440B2 (en) 2001-03-13 2001-03-13 Lipid peroxide elevation-suppressing composition containing mannooligosaccharide

Publications (2)

Publication Number Publication Date
JP2002262828A true JP2002262828A (en) 2002-09-17
JP4684440B2 JP4684440B2 (en) 2011-05-18

Family

ID=18928291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001070410A Expired - Fee Related JP4684440B2 (en) 2001-03-13 2001-03-13 Lipid peroxide elevation-suppressing composition containing mannooligosaccharide

Country Status (1)

Country Link
JP (1) JP4684440B2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006083127A (en) * 2004-09-17 2006-03-30 Ajinomoto General Foods Inc Composition having body fat reduction action and food and drink containing the same
JP2006169135A (en) * 2004-12-14 2006-06-29 Ajinomoto General Foods Inc Anti-allergen composition containing mannooligosaccharide
WO2007086100A1 (en) * 2006-01-24 2007-08-02 Ajinomoto General Foods, Inc. Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same
WO2008023425A1 (en) 2006-08-24 2008-02-28 Kirin Holdings Kabushiki Kaisha Composition for amelioration of skin condition
JP2009275047A (en) * 2009-06-30 2009-11-26 Ajinomoto General Foods Inc Composition having body fat reducing action and food and drink containing the same
JP2011132187A (en) * 2009-12-25 2011-07-07 Suntory Holdings Ltd Method for producing mannooligosaccharide
AU2012201716B2 (en) * 2004-09-17 2014-11-13 Ajinomoto General Foods, Inc. Compositions having body fat reducing function and food and drink containing the same
JP2015129126A (en) * 2015-01-06 2015-07-16 サントリーホールディングス株式会社 Method for producing mannooligosaccharide
JP2015189732A (en) * 2014-03-28 2015-11-02 味の素ゼネラルフーヅ株式会社 Dna damage inhibiting agents
JP2016179988A (en) * 2016-04-28 2016-10-13 サントリーホールディングス株式会社 Method for producing mannooligosaccharide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508745A (en) * 1982-12-30 1985-04-02 General Foods Corporation Production of a mannan oligomer hydrolysate
JPS6196947A (en) * 1984-10-19 1986-05-15 ゼネラル・フ−ヅ・コ−ポレ−シヨン Production of mannan oligomer hydrolysate
JPH02200147A (en) * 1988-09-14 1990-08-08 General Foods Corp Hydrolytic process for roasted, pulverized coffee which is not extracted perfectly
JP2002262827A (en) * 2001-03-13 2002-09-17 Ajinomoto General Foods Inc Serum lipid improving composition containing mannooligosaccharide

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508745A (en) * 1982-12-30 1985-04-02 General Foods Corporation Production of a mannan oligomer hydrolysate
JPS6196947A (en) * 1984-10-19 1986-05-15 ゼネラル・フ−ヅ・コ−ポレ−シヨン Production of mannan oligomer hydrolysate
JPH02200147A (en) * 1988-09-14 1990-08-08 General Foods Corp Hydrolytic process for roasted, pulverized coffee which is not extracted perfectly
JP2002262827A (en) * 2001-03-13 2002-09-17 Ajinomoto General Foods Inc Serum lipid improving composition containing mannooligosaccharide

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005290262B2 (en) * 2004-09-17 2012-01-12 Ajinomoto General Foods, Inc. Compositions having body fat reducing function and food and drink containing the same
EP1809328A1 (en) * 2004-09-17 2007-07-25 Ajinomoto General Foods, Inc. Compositions having body fat reducing function and food and drink containing the same
AU2012201716B2 (en) * 2004-09-17 2014-11-13 Ajinomoto General Foods, Inc. Compositions having body fat reducing function and food and drink containing the same
EP1809328A4 (en) * 2004-09-17 2007-11-14 Ajinomoto General Foods Inc Compositions having body fat reducing function and food and drink containing the same
JP2006083127A (en) * 2004-09-17 2006-03-30 Ajinomoto General Foods Inc Composition having body fat reduction action and food and drink containing the same
JP2006169135A (en) * 2004-12-14 2006-06-29 Ajinomoto General Foods Inc Anti-allergen composition containing mannooligosaccharide
JP5214978B2 (en) * 2006-01-24 2013-06-19 味の素ゼネラルフーヅ株式会社 Composition having blood pressure lowering action and / or elevation suppressing action and food and drink containing the same
WO2007086100A1 (en) * 2006-01-24 2007-08-02 Ajinomoto General Foods, Inc. Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same
WO2008023425A1 (en) 2006-08-24 2008-02-28 Kirin Holdings Kabushiki Kaisha Composition for amelioration of skin condition
JP2009275047A (en) * 2009-06-30 2009-11-26 Ajinomoto General Foods Inc Composition having body fat reducing action and food and drink containing the same
JP2011132187A (en) * 2009-12-25 2011-07-07 Suntory Holdings Ltd Method for producing mannooligosaccharide
JP2015189732A (en) * 2014-03-28 2015-11-02 味の素ゼネラルフーヅ株式会社 Dna damage inhibiting agents
JP2015129126A (en) * 2015-01-06 2015-07-16 サントリーホールディングス株式会社 Method for producing mannooligosaccharide
JP2016179988A (en) * 2016-04-28 2016-10-13 サントリーホールディングス株式会社 Method for producing mannooligosaccharide

Also Published As

Publication number Publication date
JP4684440B2 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
JP4771882B2 (en) Composition having action of treating, preventing or ameliorating diabetes or diabetic complication and beverage containing the same
DE60215310T2 (en) METHOD FOR DEHADRATING A WATER-CONTAINING MATERIAL WITH A CYCLOTETRASACCHARIDE
JPH0678367B2 (en) Dietary fiber, method for producing the same, and bioactive agent containing the dietary fiber
JP5214978B2 (en) Composition having blood pressure lowering action and / or elevation suppressing action and food and drink containing the same
JPH03244365A (en) Food composition having intestinal function controlling action
JP4488852B2 (en) Composition having body fat reducing action
FR2507867A1 (en) PROCESS FOR PREPARING A-GLYCOSYLGLYCYRRHIZINE AND APPLICATIONS THEREOF
JP3553866B2 (en) Composition based on mannooligosaccharides
JP2002262827A (en) Serum lipid improving composition containing mannooligosaccharide
JP4684440B2 (en) Lipid peroxide elevation-suppressing composition containing mannooligosaccharide
JP4307800B2 (en) Immunostimulating composition containing mannooligosaccharide
JP2972949B2 (en) Method for producing extract containing functional nutrients and method for producing candy using the extract
JP6287479B2 (en) Anticancer drug
JP4851215B2 (en) Mineral absorption promoting composition containing mannooligosaccharide
JP3515078B2 (en) Taste improvement of food and drink by coffee oligosaccharide
JP4673753B2 (en) Serum lipid improving agent containing mannooligosaccharide
JP4054697B2 (en) Constipation improving agent
JP2002306093A (en) Promoting composition including mannooligosaccharide for mineral absorption
CN1223265A (en) Process for preparing stachyose and its products and application
JP4960591B2 (en) Anti-allergen composition containing mannooligosaccharides
JP6263820B1 (en) Eating and drinking composition
JP2009275047A (en) Composition having body fat reducing action and food and drink containing the same
JP6269251B2 (en) Skin quality improver
JP6418310B2 (en) Mannopolyosyl fructose production method, oligosaccharide composition, and microorganism culture medium
JP6303714B2 (en) DNA damage inhibitor and method for producing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071004

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080522

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100812

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101012

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100922

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110111

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110209

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140218

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4684440

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees